Background and Purpose: Deficiencies in coagulant inhibitors protein C, protein S, and antithrombin III increase the risk of venous thrombosis. We describe 10 young adults with cerebral arterial thrombosis due to deficiencies in these factors.
In about 4% of young adults with cerebral infarction, the major precipitant to thrombosis is a hematologic abnormality."2 This rate probably underestimates the role of hemostatic disturbances as a cause of cerebrovascular events. Atherosclerosis is an uncommon cause of cerebral infarct in young adults.3 Cardioembolism is generally regarded as the most important cause of ischemic stroke in this age group.4,5 The etiology of the cerebral infarction remains unexplained in a significant number of young patients even after extensive investigation.6 '7 In acute ischemic stroke, usually no abnormalities are found in the routine hematologic or coagulation tests. 8 Some authors have reported the occurrence of hemostatic disturbances in young stroke patients, such as abnormalities of platelet function, coagulation inhibition, and/or fibrinolysis.9-12 Naturally occurring coagu-lation inhibitory proteins (CIP) have recently been clarified. These CIP include antithrombin III (ATIII), protein C (PC), and protein S (PS). [13] [14] [15] At the present time the natural anticoagulant pathway is becoming better appreciated and understood in the regulation of thrombosis. Although CIP deficiency usually causes venous thrombosis, it has been reported recently that cerebral arteries may be primarily involved. [16] [17] [18] [19] The CIP inhibit clotting mechanisms acting in different ways. ATIII binds to heparan on the surface of endothelial cells, increasing its ability to inhibit thrombin and other activated clotting factors.20-22 PC is an anticoagulant protease that after activation by the reaction of thrombin with thrombomodulin on the endothelial cell surface inactivates thrombin and activated factors V and VIII and also promotes fibrinolysis. PS is found free in plasma and bound to The CIP were determined within 48 hours from the onset of symptoms and before any treatment was started. Venous blood samples were obtained from an antecubital vein of the nonparalyzed arm by means of clean venipuncture using an evacuated tube containing 0.129 M sodium citrate as an anticoagulant. The sample was centrifuged at 1,600-2,00Og for 10 minutes, and the plasma was stored at -70°C until assayed.
The quantitative study of PC antigen and free PS antigen (after separation and precipitation of bound PS with polyethylene glycol) was performed immunologically by Laurell rocket electrophoresis using sheep or goat antiserum to human PC or human PS, respectively.25 These antibodies were obtained from Helena Laboratories, Beaumont, Tex., and were incorporated into agarose in tris(hydroxymethyl)aminomethane (Tris)-tricine buffer. The results for PC antigen and free PS antigen were expressed as the relative percentage compared with a pooled normal plasma standard. The expected normal range for PC antigen was 65-145%, and the coefficient of variation (CV) for this assay was 3.0% in a within-run reproducibility study. The normal range for free PS antigen was 60-150% with a CV of 5.2% in a within-run reproducibility study performed in five donor samples. The quantitative analysis of ATIII was performed by radial immunodiffusion26 using goat anti-human ATIII (Helena) added to the agarose. The results were reported in milligrams per deciliter; the normal range obtained in our laboratory was 9-14 mg/dl. Within-run reproducibility was determined performing an ATIII assay on 10 donor samples; the CV obtained was 4 Results In one third of the 60 patients the probable etiology of the cerebral infarct was undetermined. Four patients died within 3 months of their cerebrovascular event, two of systemic medical complications and two of underlying heart or vascular diseases (myocardial infarction and Takayasu's disease). Fifty-five patients (92%) had cerebral infarction in the carotid territory and five in the brain stem (two with lateral medullary infarct, two with lateral pontine infarct, and one with mesencephalic infarct). The infarct was demonstrated on CT in 52 patients and by MRI in the remaining eight.
In 10 patients (17%) the acute ischemic stroke was attributed to a hematologic disorder. This group of patients comprised six men and four women, with a mean age of 31.4 (range, 24-38) years; there was no significant difference in mean age between women and men. Table 1 summarizes the clinical features of these 10 patients at the time of admission. Cerebral angiography was performed in nine patients, which showed either an occluded vessel or partial filling intravascular defect in eight. Four of these patients had unilateral internal carotid artery occlusion (Figure 1 ). In one case the angiogram was normal and free of atherosclerosis. The median interval from the ictus to angiography was 5 days. The MRI demonstrated isointense or hypointense lesions on Ti-weighted images (Figure 2 , left panel) and hyperintense lesions on T2-weighted images ( Figure 2 , right panel and Figure 3 , left panels) corresponding to the occluded vessels in all cases. The CT was normal in one of nine patients. The carotid territory was involved in these 10 cases.
The routine hematologic tests were normal in the 10 reported cases. The immunologic studies in cerebrospinal fluid for cisticercosis and tuberculosis performed in two patients were also normal. The antinuclear and anticardiolipin antibodies were positive in only one patient (No. 5) . The quantitative analysis of the CIP showed ATIII deficiency in five patients, PC deficiency in three men, and PS deficiency in two women. None of these patients had previous systemic venous thrombosis.
Eight patients had associated clinical conditions that probably promoted stasis or a prothrombotic state. Of the three men with cerebral infarction secondary to PC The measurements of PC, PS, and ATIII were normal in all the relatives studied. All patients were treated with antiplatelet drugs, with complete recovery in eight. MRI follow-up showed a decrement in size of the lesion in these subjects ( Figure 3 , right panels). There was no mortality; morbidity was present in two subjects, one with PS deficiency (left hemiplegia) and one with ATIII deficiency (lower left monoparesis). No correlation was observed between morbidity, outcome, and the proportion of CIP deficiency.
The determinations of CIP at 3 months after the stroke showed that the values remained low in subjects with PC deficiency, in one patient with PS deficiency, and in three ATIII-deficient patients ( In 21 patients (35%) the etiology of the stroke remained undetermined. A hematologic disorder was implied as the etiology of the cerebral infarct in 10 subjects (17%). Our rate of stroke of unexplained origin appears to be lower than that in other reports in this age group.67 The high incidence of hematologic diseases may reflect a selection bias in the present series.
In contrast with other reports that failed to document deficiencies in the CIP in stroke patients,7 we found PC deficiency in three men, PS deficiency in two women, and ATIII deficiency in two women and three men. All these subjects were negative for hypertension, hyperlipidemia, valvular or ischemic cardiac disease, and transient ischemic attacks. Atherosclerosis, carotid or vertebrobasilar dissection, and fibromuscular dysplasia were excluded by means of cerebral angiography. Other etiologies commonly observed in our country such as cysticercosis and tuberculosis were excluded through immunologic cerebrospinal fluid studies. No abnormalities were observed in the routine coagulation profile. Lupus anticoagulant was negative in all patients, whereas antinuclear antibodies were positive in a patient with a history of rheumatoid arthritis (No. 5), which was inactive at the onset of the cerebrovascular event.
In patients with PC deficiency there was an associated disorder that acted in synergy with this deficient protein and may have promoted thrombosis in cerebral vasculature. PC is a vitamin K-dependent zymogen of a plasma serine protease.17-19 After in vivo activation by the reaction of thrombin with endothelial thrombomodulin, it inhibits blood coagulation by inactivating factors Va and Vllla.13 It is also involved in the regulation of It has been estimated that the prevalence of hereditary ATIII deficiency is 1: 2,000-1:5,000 in the general population.22 However, the prevalence.of hereditary PC or free PS deficiency remains unsettled. Thus, the incidence of stroke among persons with hereditary deficiencies of these CIP is unknown. Acquired deficiencies of the CIP have been reported in malignancies, plasmapheresis, hemodialysis, nephrotic syndrome, hepatic failure, pregnancy, and in women taking oral contraceptives.14 There was an acquired deficiency in three patients in the present series: a patient with PS deficiency and two patients with ATIII deficiency.
Hematologic causes of ischemic stroke are most often described in young adults.2 In this age group the atherosclerotic mechanisms are less likely than in older patients.3 When a hematologic abnormality is identified after a cerebrovascular event, it cannot be assumed to antedate stroke. 15 To support antedating, the abnormality should remain present in the following months or be present in family members. In our patients, the values of PC (three patients), PS (one patient), and ATIII (three patients) remained low at 3 months after the stroke, supporting the hypothesis that these deficiencies were the cause rather than the consequence of the stroke.
An understanding of clotting mechanisms and the more complete laboratory screening performed in stroke patients should permit recognition of more hematologic abnormalities as a cause of cerebral infarct. A knowledge of these new pathophysiological mechanisms will enable the clinician to improve the prevention and treatment of this devastating neurological disease.
